What is Biohaven's net investment in lease?

Biohaven (BHVN) reported net investment in lease of $43.4M in Q1 2026.

How has Biohaven's net investment in lease changed year-over-year?

Biohaven's net investment in lease increased by 22.5% year-over-year, from $35.43M to $43.4M.

What is the long-term trend for Biohaven's net investment in lease?

Over 4 years (2021 to 2025), Biohaven's net investment in lease has grown at a 71.4% compound annual growth rate (CAGR), from $5.22M to $45.06M.

Biohaven BHVN Net Investment in Lease

Net Investment in Lease at other companies

Xenon PharmaceuticalsXENE

——

Rapport Therapeutics, Inc.RAPP

——

Vir Biotechnology, Inc.VIR

——

uniQureQURE

——

Roivant SciencesROIV

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.23B-48.1%

Enterprise value$2.23B-46.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's net investment in lease?: Biohaven (BHVN) reported net investment in lease of $43.4M in Q1 2026.
How has Biohaven's net investment in lease changed year-over-year?: Biohaven's net investment in lease increased by 22.5% year-over-year, from $35.43M to $43.4M.
What is the long-term trend for Biohaven's net investment in lease?: Over 4 years (2021 to 2025), Biohaven's net investment in lease has grown at a 71.4% compound annual growth rate (CAGR), from $5.22M to $45.06M.